In a groundbreaking announcement at last week's San Antonio Breast Cancer Symposium, researchers revealed life-changing results from the PATINA clinical trial - a study poised to redefine the treatment of metastatic breast cancer. For women diagnosed with hormone receptor (HR) positive, HER-2 positive metastatic breast cancer, the addition of the drug Palbociclib to standard treatments…
